News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: pphmtoolong post# 266602

Sunday, 06/12/2016 10:31:50 PM

Sunday, June 12, 2016 10:31:50 PM

Post# of 347009

but whether Mother Nature wanted the anti-PS approach to be a significant cancer/virus fighter. As of now, Mother Nature has given us the cold shoulder.



I disagree 100%

Have you read the 100's of PS related publications, detailing how flipped PS "IS" is a biomarker of disease/cancer...etc ?

Even the experts agree below, see CJ's post.... and hmmm, maybe that is why NCCN, AstraZeneca and MSK jumped on board?

Are you telling me that NCCN, AstraZeneca and MSK all jump on board "highly speculative" biotechs ? : )

When some try to force the focus and say we should be seeing something else verse what I see clearly.... then I question that line of thought.

Damn... I say Fargo was because PS Targeting is "highly on target" and PS Targeting remains the target for IO combo's.

--------------------------------------------


“Phosphatidylserine is a Global Immunosuppressive Signal in Efferocytosis, Infectious Disease, and Cancer”

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120805096


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y